Commercial opportunities and ethical pitfalls in personalized medicine: a myriad of reasons to revisit the Myriad Genetics saga
So, D., Joly, Y., “Commercial opportunities and ethical pitfalls in personalized medicine: a myriad of reasons to revisit the Myriad Genetics saga” 11:2 (2013) Pharmacogenomics and Personalized Medicine 98-109.
Ce contenu a été mis à jour le 18 janvier 2016 à 12 h 56 min.